Davis Aaron I. - Mar 22, 2022 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role: Director
Signature: /s/ Aaron I. Davis
Stock symbol: ITOS
Transactions as of: Mar 22, 2022
Transactions value $: $1,625,489
Form type: 4
Date filed: 3/24/2022, 09:00 PM
Previous filing: Jan 18, 2022
Next filing: May 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITOS	Common Stock	Purchase	$679K	+21.3K	+0.68%	$31.88	3.16M	Mar 22, 2022	See footnote	F1
transaction	ITOS	Common Stock	Purchase	$122K	+3.7K	+0.12%	$33.09	3.17M	Mar 22, 2022	See footnote	F1
transaction	ITOS	Common Stock	Purchase	$167K	+5K	+0.16%	$33.43	3.17M	Mar 22, 2022	See footnote	F1
transaction	ITOS	Common Stock	Purchase	$657K	+20K	+0.63%	$32.85	3.19M	Mar 23, 2022	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.

Content

These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.